Site-specific modification of Epstein-Barr virus-encoded RNA 1 with N2-benzylguanosine limits the binding sites occupied by PKR.
Puthenveetil
Sujiet
S
University of Utah, Department of Chemistry, Salt Lake City, Utah 84112, USA.
Véliz
Eduardo A
EA
Beal
Peter A
PA
D001665:Binding Sites; D004492:Edetic Acid; D005296:Ferrous Compounds; D006151:Guanosine / Q000031:analogs & derivatives* / Q000737:chemistry*; D006801:Humans; D009943:Organophosphorus Compounds; D012367:RNA, Viral / Q000138:chemical synthesis* / Q000737:chemistry / Q000378:metabolism; D019892:eIF-2 Kinase / Q000378:metabolism*
C099537:Epstein-Barr virus encoded RNA 1; D005296:Ferrous Compounds; C492556:N2-benzylguanosine; D009943:Organophosphorus Compounds; D012367:RNA, Viral; C434331:phosphoramidite; D006151:Guanosine; C055526:Fe(II)-EDTA; D004492:Edetic Acid; D019892:eIF-2 Kinase